CIPRX Performance — Champlain Strategic Focus Fund

Data updated: 2026-08-28

In the 12 months to Jun 2026 the fund lost a net $308K, and assets reached $3.74M.

CIPRX Growth of $100

What $100 invested in Champlain Strategic Focus Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Growth category average over the same months.

PeriodCIPRXCategory average
Since data start (Apr 2026 – Jun 2026)$114$118

CIPRX Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+13.91%

CIPRX Annual Returns

Calendar-year total returns of Champlain Strategic Focus Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Apr–Jun)+13.91%

CIPRX Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026———+3.0%+7.5%+2.9%——————

CIPRX Risk

Risk measures from monthly returns over Apr 2026 – Jun 2026.

  • Best month: +7.53% (May 2026)
  • Worst month: +2.89% (Jun 2026)

CIPRX Fund Flows

Monthly money in and out of Champlain Strategic Focus Fund, from SEC Form N-PORT.

  • 12-month net flow: −$308K
  • 12-month gross sales (incl. reinvestments): $319K
  • Sales ÷ redemptions: 0.51×
MonthSalesRedemptionsNet flow
Jun 2026$895$280K−$279K
May 2026$755$126K−$126K
Apr 2026$139K$3K$136K
Mar 2026$857$19K−$18K
Feb 2026$101K$100K$745
Jan 2026$13K$0$13K
Dec 2025$1K$26K−$25K
Nov 2025$880$1K−$216
Oct 2025$58K$72K−$14K
Sep 2025$1K$142$1K
Aug 2025$2K$59$2K
Jul 2025$1K$0$1K

CIPRX Assets Under Management

Net assets of Champlain Strategic Focus Fund by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$3.74M
2026-03-31$3.56M
2025-12-31$3.95M
2025-09-30$4.19M
2025-06-30$4.04M
2025-03-31$3.40M
2024-12-31$3.13M
2024-09-30$2.69M
2024-06-30$2.58M
2024-03-31$2.62M
2023-12-31$2.38M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.